BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9327985)

  • 1. Agmatine: a novel neurotransmitter?
    Reis DJ; Regunathan S
    Adv Pharmacol; 1998; 42():645-9. PubMed ID: 9327985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agmatine: an endogenous clonidine-displacing substance in the brain.
    Li G; Regunathan S; Barrow CJ; Eshraghi J; Cooper R; Reis DJ
    Science; 1994 Feb; 263(5149):966-9. PubMed ID: 7906055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agmatine: an endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain.
    Reis DJ; Regunathan S
    J Auton Nerv Syst; 1998 Oct; 72(2-3):80-5. PubMed ID: 9851555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agmatine: an endogenous ligand at imidazoline receptors is a novel neurotransmitter.
    Reis DJ; Regunathan S
    Ann N Y Acad Sci; 1999 Jun; 881():65-80. PubMed ID: 10415899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary adenylate-cyclase activating polypeptide (PACAP) evokes long-lasting secretion and de novo biosynthesis of bovine adrenal medullary neuropeptides.
    Babinski K; Bodart V; Roy M; De Léan A; Ong H
    Neuropeptides; 1996 Dec; 30(6):572-82. PubMed ID: 9004256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade by agmatine of catecholamine release from chromaffin cells is unrelated to imidazoline receptors.
    Santos WC; Hernández-Guijo JM; Ruiz-Nuño A; Olivares R; Jurkiewicz A; Gandía L; García AG
    Eur J Pharmacol; 2001 Apr; 417(1-2):99-109. PubMed ID: 11301064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha2-adrenoceptors in adrenomedullary chromaffin cells: functional role and pathophysiological implications.
    Artalejo AR; Olivos-Oré LA
    Pflugers Arch; 2018 Jan; 470(1):61-66. PubMed ID: 28836008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Agmatine--an endogenous ligand of imidazoline receptors].
    Kozaeva LP; Korobov NV
    Eksp Klin Farmakol; 2003; 66(5):69-73. PubMed ID: 14650220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An antibody to agmatine localizes the amine in bovine adrenal chromaffin cells.
    Wang H; Regunathan S; Youngson C; Bramwell S; Reis DJ
    Neurosci Lett; 1995 Jan; 183(1-2):17-21. PubMed ID: 7746477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.
    Brindley RL; Bauer MB; Hartley ND; Horning KJ; Currie KPM
    J Neurochem; 2017 Oct; 143(2):171-182. PubMed ID: 28815595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydralazine reduces the quantal size of secretory events by displacement of catecholamines from adrenomedullary chromaffin secretory vesicles.
    Machado JD; Gómez JF; Betancor G; Camacho M; Brioso MA; Borges R
    Circ Res; 2002 Nov; 91(9):830-6. PubMed ID: 12411398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular responses to agmatine, a clonidine-displacing substance, in anesthetized rat.
    Sun MK; Regunathan S; Reis DJ
    Clin Exp Hypertens; 1995; 17(1-2):115-28. PubMed ID: 7735262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous ligands of imidazoline receptors: classic and immunoreactive clonidine-displacing substance and agmatine.
    Reis DJ; Li G; Regunathan S
    Ann N Y Acad Sci; 1995 Jul; 763():295-313. PubMed ID: 7677340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short term effect of steroids on catecholamine secretion from bovine adrenal medulla chromaffin cells.
    Dar DE; Zinder O
    Neuropharmacology; 1997; 36(11-12):1783-8. PubMed ID: 9517452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition by pregnenolone sulfate of nicotinic acetylcholine response in adrenal chromaffin cells.
    Kudo K; Tachikawa E; Kashimoto T
    Eur J Pharmacol; 2002 Dec; 456(1-3):19-27. PubMed ID: 12450565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiles of secreted neuropeptides and catecholamines illustrate similarities and differences in response to stimulation by distinct secretagogues.
    Podvin S; Bundey R; Toneff T; Ziegler M; Hook V
    Mol Cell Neurosci; 2015 Sep; 68():177-85. PubMed ID: 26092702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes.
    Brede M; Nagy G; Philipp M; Sorensen JB; Lohse MJ; Hein L
    Mol Endocrinol; 2003 Aug; 17(8):1640-6. PubMed ID: 12764077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-release of enkephalin and catecholamines from cultured adrenal chromaffin cells.
    Livett BG; Dean DM; Whelan LG; Udenfriend S; Rossier J
    Nature; 1981 Jan; 289(5795):317-9. PubMed ID: 7453829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of nicotinic receptors by opiate receptor agonists in cultured adrenal chromaffin cells.
    Kumakura K; Karoum F; Guidotti A; Costa E
    Nature; 1980 Jan; 283(5746):489-92. PubMed ID: 6243403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.
    Piletz JE; Chikkala DN; Ernsberger P
    J Pharmacol Exp Ther; 1995 Feb; 272(2):581-7. PubMed ID: 7853171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.